Active Ingredient(s):Anakinra FDA Approved: * November 14, 2001 Pharm Company: *AMGEN Category:Arthritis
Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean fever, and Still's disease. It is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. It is marketed by Swedish Orphan Biovitrum. Anakinra is administered by subcutaneous injection.
* May have multiple approval dates, manufacturers, or labelers. 3 Discussions